Give examples for each stage in ann and arbor staging of NHL

Reading File

Finding Sources

Reading File

I now have comprehensive textbook content. Here is a detailed breakdown of the Ann Arbor staging system for Non-Hodgkin Lymphoma (NHL) with clinical examples for each stage.

Ann Arbor Staging of Non-Hodgkin Lymphoma (NHL)

Originally developed in 1971 for Hodgkin lymphoma, the Ann Arbor system was adapted for NHL. It classifies disease based on number of tumor sites (nodal and extranodal), location relative to the diaphragm, and presence/absence of systemic (B) symptoms.

Stage Definitions & Examples

Stage I

Single lymph node region (I) or a single extranodal site (IE)

Subtype	Example
I	Isolated right cervical (neck) lymphadenopathy from follicular lymphoma, with no other nodal or organ involvement
IE	A solitary extranodal mass — e.g., primary gastric MALT lymphoma confined to the stomach wall, without any nodal involvement

Stage II

Two or more lymph node regions on the same side of the diaphragm (II), or with contiguous extranodal involvement (IIE)

Subtype	Example
II	Enlarged cervical and ipsilateral axillary lymph nodes (both above the diaphragm) in a patient with DLBCL — no organ involvement
IIE	Mediastinal and bilateral hilar lymphadenopathy plus contiguous involvement of the adjacent lung parenchyma (all above the diaphragm)

Stage III

Lymph node regions on both sides of the diaphragm (III), possibly with spleen (IIIS), contiguous extranodal site (IIIE), or both (IIIES)

Subtype	Example
III	Cervical lymphadenopathy (above diaphragm) + para-aortic lymphadenopathy (below diaphragm) in follicular lymphoma
IIIS	Same as above, but with splenic involvement detected on PET/CT
IIIE	Bilateral cervical + retroperitoneal nodes + contiguous involvement of one kidney
IIIES	Mediastinal + mesenteric nodes + splenic involvement + contiguous involvement of the small bowel

Stage IV

Diffuse or disseminated involvement of one or more extranodal organs, with or without lymph node involvement

Example
DLBCL with widespread lymphadenopathy + bone marrow infiltration (the classic Stage IV indicator)
NHL with liver involvement (hepatic parenchymal deposits) + multiple nodal sites
Burkitt lymphoma involving multiple organs — kidneys, liver, and CNS — alongside nodal disease
Follicular lymphoma with peripheral blood lymphocytosis (leukemic phase) + nodal disease

A and B Suffixes (Apply to All Stages)

Suffix	Meaning	Example
A	No systemic symptoms	Stage IIA = bilateral cervical + axillary nodes, no fevers/sweats/weight loss
B	Presence of: unexplained fever >38°C, drenching night sweats, OR weight loss >10% body weight over 6 months	Stage IIIB = bilateral nodes on both sides of diaphragm + night sweats

Additional Notation

E = Extranodal contiguous extension (e.g., IIE, IIIE)
S = Splenic involvement (e.g., IIIS)
X = Bulky disease (mass >10 cm or mediastinal mass >1/3 chest diameter)

Key Caveat for NHL

The Ann Arbor system is less clinically useful for NHL than for Hodgkin lymphoma because NHL does not spread in an orderly stepwise nodal fashion. The majority of NHL patients already have advanced-stage (III–IV) disease at diagnosis. As a result, histology and the International Prognostic Index (IPI) — incorporating age, LDH, performance status, stage, and extranodal sites — are more important determinants of prognosis and therapy than stage alone.

Sources: Harrison's Principles of Internal Medicine 22E, p. 904 | Robbins & Kumar Basic Pathology, p. 421 | Goldman-Cecil Medicine

What is mean by non nodal site

Finding Sources

Reading File

In the context of Ann Arbor staging, "non-nodal site" is the same as an extranodal site — meaning lymphoma arising in or spreading to organs and tissues that are NOT lymph nodes.

What Counts as a "Non-Nodal" (Extranodal) Site?

Lymphoma normally originates in lymphoid tissue — lymph nodes, spleen, thymus, tonsils, Waldeyer's ring. When it involves tissue outside these lymphoid structures, that is called an extranodal site.

Common Extranodal Sites in NHL

Category	Specific Sites
GI tract (most common overall)	Stomach, small bowel, large bowel
CNS	Brain, spinal cord, meninges
Bone marrow	Diffuse infiltration → Stage IV
Liver	Parenchymal deposits
Lung	Pulmonary parenchyma
Skin	Cutaneous T-cell lymphomas (e.g., mycosis fungoides)
Bone	Osseous lesions
Orbit/eye	Orbital MALT lymphoma
Kidney/adrenal	Renal parenchyma
Testes	Testicular DLBCL
Breast	Breast lymphoma
Thyroid	Thyroid MALT lymphoma

How It Affects Staging

In Ann Arbor staging, extranodal involvement is denoted with the letter "E":

Situation	Stage	What it means
Single extranodal site, no nodal disease	IE	e.g., gastric MALT confined to stomach
Nodal disease + contiguous extranodal extension	IIE / IIIE	e.g., mediastinal nodes + adjacent lung
Disseminated (non-contiguous) extranodal organs	IV	e.g., bone marrow + liver involvement

Key distinction:

IE / IIE / IIIE → extranodal involvement that is contiguous (directly adjacent/extending from a nodal site)
Stage IV → extranodal involvement that is diffuse/disseminated and not simply contiguous spread

Why It Matters Clinically

~35% of NHL cases arise primarily at an extranodal site, with only regional nodal involvement
Extranodal disease is more common in children, immunocompromised patients (e.g., HIV), and aggressive NHL subtypes
Subtypes with a particular tendency for extranodal sites: MALT lymphoma, Mantle cell lymphoma, Burkitt lymphoma, Lymphoblastic lymphoma
Extranodal involvement is a recognized adverse prognostic factor and contributes to a higher IPI score (>1 extranodal site = 1 IPI risk point)

Source: Grainger & Allison's Diagnostic Radiology, p. 1673–1674 | Harrison's Principles of Internal Medicine 22E

Create a reference guide on primary extranodal lymphomas by organ site

Finding Sources

Reading File

Finding Sources

Reading File

Here is a comprehensive reference guide on primary extranodal lymphomas organized by organ site.

Primary Extranodal Lymphomas — Reference Guide by Organ Site

Overview

Primary extranodal lymphoma (PEL) is defined as lymphoma that arises in an organ or tissue outside the lymph nodes, with the bulk of disease at the extranodal site and regional nodes involved at most. ~35% of all NHL cases are primarily extranodal. The GI tract is the single most common site overall.

1. Stomach (Most Common Extranodal Site)

Feature	Details
Frequency	Accounts for 68–75% of all primary GI lymphomas; 5% of all gastric neoplasms
Histology	MALT (marginal zone B-cell) lymphoma 40–50%; DLBCL 45–60%; rarely T-cell, mantle cell, follicular
Pathogenesis	Gastric MALT arises from acquired lymphoid tissue triggered by Helicobacter pylori infection — the stomach normally has no MALT
Key fact	H. pylori eradication leads to regression of MALT lymphoma in 50–80% of cases
Staging	Ann Arbor IE/IIE; Paris Staging System preferred for GI lymphomas
Treatment	MALT: H. pylori eradication first-line → radiation for refractory. DLBCL: R-CHOP ± radiation; surgery no longer routine
Prognosis	MALT is indolent; DLBCL is aggressive

2. Small Bowel & Other GI Tract

Feature	Details
Histology	MALT lymphoma (western world); Immunoproliferative small intestinal disease (IPSID / Mediterranean lymphoma) in Middle East/North Africa
Special forms	Enteropathy-associated T-cell lymphoma (EATL) — complication of celiac disease; Burkitt lymphoma — common in children, involving ileocecal region
Presentation	Abdominal pain, obstruction, malabsorption, perforation
Mantle cell lymphoma	Can manifest as multiple lymphomatous polyposis throughout the bowel

3. Central Nervous System (CNS)

Feature	Details
Frequency	2% of extranodal lymphomas; 1% of all intracranial tumors
Histology	Almost exclusively DLBCL
Immunocompromised	Most common CNS neoplasm in HIV/AIDS patients; EBV-driven in this setting
Immunocompetent	Frequency increases after age 60
Location	Deep gray structures, periventricular white matter; often multifocal; may also involve the vitreous/retina (vitreoretinal lymphoma)
Key fact	Spread outside the CNS (to nodes/bone marrow) is rare and late; conversely, systemic lymphoma spreads to meninges/CSF, not brain parenchyma
Treatment	High-dose methotrexate-based chemotherapy ± cytarabine, rituximab; whole-brain radiation no longer first-line (inferior to chemo alone); autologous BMT for consolidation in eligible patients
Prognosis	Worse than nodal DLBCL

4. Thyroid

Feature	Details
Frequency	<5% of thyroid malignancies; <2% of all extranodal lymphomas
Demographics	Middle-aged to older women (F:M = 3:1); usually >50 years
Histology	DLBCL 60–70%; MALT lymphoma 10–20%; up to 1/3 have concurrent MALT + DLBCL (MALT transformation)
Risk factor	Hashimoto thyroiditis increases risk 70–80-fold; 90% of cases have coexisting HT
Presentation	MALT: slowly enlarging mass. DLBCL: rapidly growing neck mass with compressive symptoms (dyspnea, dysphagia, stridor, hoarseness)
Staging	Most present at Stage IE or IIE
Diagnosis	Open biopsy preferred (FNA often insufficient; MALT hard to diagnose on needle biopsy)
Treatment	DLBCL: R-CHOP ± IFRT (combined modality). MALT: RT is important (not curable with chemo alone). Surgery has no role in DLBCL

5. Orbit / Ocular Adnexa

Feature	Details
Histology	Predominantly low-grade MALT lymphoma of lacrimal gland and orbital adnexa
Demographics	Peak age 50–70 years; can occur younger in immunosuppressed patients
Presentation	Painless proptosis, diplopia, visual disturbances (insidious onset)
Imaging	MRI: intermediate T1/T2 signal, gadolinium enhancement; PET-positive; bone destruction rare (suggests high-grade)
Key point	May represent isolated primary disease OR initial presentation of systemic lymphoma — full-body staging + bone marrow biopsy required in all cases
Associations	Chlamydia psittaci infection implicated in some geographic regions
Treatment	Radiation therapy for localized MALT; rituximab-based chemotherapy for systemic disease

6. Lung (Pulmonary)

Feature	Details
Frequency	<0.5% of primary lung neoplasms; rare despite >50% of systemic lymphoma patients having some lung involvement
Histology	MALT (BALT — bronchus-associated lymphoid tissue) lymphoma accounts for 70–90% of primary pulmonary lymphomas
Demographics	Seventh decade; slight female predominance
Association	Sjögren syndrome in ~1/3 of cases
Symptoms	40% asymptomatic; others: cough, dyspnea, fever, night sweats, hemoptysis
CT findings	Alveolar consolidation with air bronchograms, ground-glass opacities, nodules, cysts — often multiple and bilateral
Histology triad	Reactive germinal centers + diffuse centrocyte-like infiltration + lymphoepithelial lesions
Lab	Monoclonal gammopathy in up to 60%
Treatment	Surgical resection for localized disease; rituximab ± chemotherapy for disseminated; excellent prognosis for MALT

7. Testis

Feature	Details
Frequency	2–5% of testicular neoplasms; most common testicular tumor in men >60 years
Histology	Predominantly DLBCL; also Burkitt lymphoma; EBV+ extranodal NK/T-cell lymphoma
Behavior	Aggressive; frequently disseminated at diagnosis
Bilaterality	Frequently bilateral (unlike germ cell tumors); often involves spermatic cord
Key danger	High propensity for CNS involvement — frequent site of relapse
Belongs to	WHO category: "Large B-cell lymphoma of immune-privileged sites" (alongside primary CNS lymphoma and vitreoretinal lymphoma)
Treatment	R-CHOP + CNS prophylaxis (intrathecal chemotherapy) + contralateral testicular irradiation

8. Breast

Feature	Details
Histology	Primarily B-cell; most common subtype DLBCL
Special form	Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) — T-cell lymphoma arising in the fibrous capsule of textured breast implants (ALK-negative ALCL)
Presentation	Painless breast mass; may mimic carcinoma
Treatment	R-CHOP for DLBCL; BIA-ALCL: implant removal + capsulectomy (often curative for localized disease)

9. Bone

Feature	Details
Frequency	~5% of all primary bone neoplasms
Demographics	Males in their 40s predominate; long bones > spine
Histology	Diffuse large B-cell lymphoma
Presentation	Bone pain, pathological fracture, soft tissue mass
Imaging	MRI superior for local staging — shows extent of marrow infiltration and extraosseous spread
Treatment	Combined modality: R-CHOP chemotherapy + involved-field radiotherapy
Prognosis	Generally favorable for localized disease

10. Waldeyer's Ring (Tonsil/Nasopharynx)

Feature	Details
Frequency	Most common head & neck extranodal lymphoma site; >50% of extranodal head and neck lymphomas
Sites	Palatine tonsil > nasopharynx > base of tongue > soft palate
Histology	DLBCL predominates
Association	Concurrent GI involvement should be evaluated (lymphocytic homing phenomenon)

Quick Comparison Summary

Site	Most Common Histology	Key Association	Stage at Presentation
Stomach	MALT / DLBCL	H. pylori	IE–IIE
CNS	DLBCL	HIV/EBV (immunocompromised)	Stage I (isolated CNS)
Thyroid	DLBCL / MALT	Hashimoto thyroiditis	IE–IIE
Orbit	MALT	Sjögren / Chlamydia	IE–IIE
Lung	MALT (BALT)	Sjögren syndrome	IE–IIE
Testis	DLBCL	Age >60, immune-privileged	Often III–IV
Breast	DLBCL / BIA-ALCL	Implants (ALCL)	IE–IIE
Bone	DLBCL	Males, long bones	IE–IIE
Waldeyer's Ring	DLBCL	GI co-involvement	IE–IIE

Sources: Robbins & Cotran Pathologic Basis of Disease | Harrison's Principles of Internal Medicine 22E | Fishman's Pulmonary Diseases and Disorders | Sleisenger & Fordtran's GI and Liver Disease | Cummings Otolaryngology | Grainger & Allison's Diagnostic Radiology | Schwartz's Principles of SurgeryThe reference guide covers 10 primary extranodal sites. A few high-yield patterns worth memorizing:

MALT lymphoma is the dominant histology at indolent mucosal sites (stomach, lung, orbit, thyroid) and typically presents at early stage (IE–IIE)
DLBCL dominates at aggressive sites (CNS, testis, bone, breast) and tends to be disseminated at diagnosis
Three sites share the WHO designation "immune-privileged": CNS, testis, and vitreoretinal — all are DLBCL, all carry high CNS relapse risk
Infection-driven MALT: H. pylori (stomach), Sjögren syndrome (lung/orbit), Hashimoto thyroiditis (thyroid), Chlamydia psittaci (orbit)

How come a lymphoma arises from a non nodal site

Finding Sources

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

Generate a PDF quick-reference on extranodal lymphoma pathogenesis mechanisms

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

This is a shared conversation. Sign in to Orris to start your own chat.